Position in MRK
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$6,237,775
+$508,844 QoQ
Shares Held
48,543
+1.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#947
of 3,778 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 71%
Shared 0%
None 29%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Dana Investment Advisors, Inc. holds $103,613,510 across 8 Drug Manufacturers - General names. MRK ranks #4 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
35,592 | $42,690,116 | |
| 2 | ABBV |
AbbVie Inc.
|
157,662 | $39,674,065 | |
| 3 | JNJ |
Johnson & Johnson
|
34,927 | $8,870,410 | |
| 4 | MRK |
Merck & Co., Inc.
This page
|
48,543 | $6,237,775 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
44,825 | $2,582,816 | |
| 6 | PFE |
Pfizer Inc
|
75,072 | $1,807,733 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
9,640 | $1,217,917 | |
| 8 | AMGN |
Amgen Inc
|
1,471 | $532,678 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $6,237,775 | 48,543 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $5,728,931 | 47,626 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $4,732,594 | 44,961 | Shares | Sole | 2026-02-05 | |
| 2025-09-30 | $3,781,466 | 45,055 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $3,342,926 | 42,230 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $4,077,707 | 45,429 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $14,128,945 | 142,028 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $20,068,209 | 176,719 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $22,366,327 | 180,665 | Shares | Sole | 2024-08-27 | |
| 2024-03-31 | $25,171,177 | 190,763 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $20,091,186 | 184,289 | Shares | Sole | 2024-02-07 | |
| 2023-09-30 | $21,457,765 | 208,429 | Shares | Sole | 2023-11-15 | |
| 2023-06-30 | $19,829,079 | 171,844 | Shares | Sole | 2023-08-15 | |
| 2023-03-31 | $19,676,724 | 184,949 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $23,036,992 | 207,634 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $18,584,437 | 215,797 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $22,919,864 | 251,397 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $22,855,027 | 278,550 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $14,826,467 | 193,456 | Shares | Sole | 2022-02-09 | |
| 2021-09-30 | $3,197,808 | 42,575 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,220,300 | 41,408 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $2,798,214 | 36,298 | Shares | Sole | 2021-05-13 | |
| 2020-12-31 | $22,945,953 | 280,513 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $21,679,987 | 261,362 | Shares | Sole | 2020-11-10 | |
| 2020-06-30 | $22,347,761 | 288,992 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $24,759,358 | 321,801 | Shares | Sole | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||